| Single Dose Administration of Ketamine 10, 20, 40 and 80 mg and 5 mg Solution for Infusion in 15 Healthy Subjects (NCT02494830) | University Medicine Greifswald | 2014-08-01 |
| Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405 (NCT02387554) | Hanmi Pharmaceutical Company Limited | 2014-08-01 |
| Injection With OnabotulinumtoxinA (Botox) for the Treatment of Chronic Pelvic Pain (NCT02173405) | University Hospitals Cleveland Medical Center | 2014-08-01 |
| Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) (NCT02000362) | Kang Stem Biotech Co., Ltd. | 2014-08-01 |
| Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy (NCT02185937) | Radboud University Medical Center | 2014-08-01 |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Repeat Doses of RV1729 for 28 Days in Patients With COPD (NCT02140346) | Respivert Ltd | 2014-08-01 |
| Safety, Tolerability and Performance of SmartMatrix Dermal Replacement Scaffold (NCT02059252) | Smart Matrix Limited | 2014-08-01 |
| Effects of Delayed Cord Clamp and/or Indomethacin on Preterm Infant Brain Injury (NCT02221219) | Hong Huang | 2014-08-01 |
| F901318 Single Ascending Dose Study in Healthy Male Volunteers (NCT02142153) | F2G Ltd | 2014-08-01 |
| Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312 (NCT02676830) | Kowa Research Institute, Inc. | 2014-08-01 |
| Crossover Study to Evaluate the Relative Bioavailability and Palatability of a Lenvatinib Suspension Compared to the Capsule Formulation in Adult Healthy Volunteers (NCT02792829) | Eisai Inc. | 2014-08-01 |
| A Study to Evaluate the Pharmacokinetics and Safety of Cobimetinib in Volunteers With and Without Liver Damage (NCT02300025) | Genentech, Inc. | 2014-08-01 |
| Bioavailability Study of SPARC1210 and Reference1210 in Subjects With Metastatic Breast Cancer (NCT02136927) | Sun Pharma Advanced Research Company Limited | 2014-08-01 |
| Absolute Bioavailability, Safety, and Tolerability of Subcutaneous GS-5745 in Healthy Adults (NCT02209987) | Gilead Sciences | 2014-08-01 |
| Drug-Drug Interaction Study in Health Adult Volunteers (NCT02273986) | Kowa Research Institute, Inc. | 2014-08-01 |
| Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer (NCT02089334) | Rexahn Pharmaceuticals, Inc. | 2014-08-01 |
| A Pharmacokinetics, Pharmacodynamics, and Safety Study of an Oral Contraceptive Containing Norethindrone and Ethinyl Estradiol When Co-administered With GSK1322322 in Healthy Adult Women (NCT01953809) | GlaxoSmithKline | 2014-08-01 |
| Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BMS-986120 in Healthy Subjects and the Effects of Co-Administration of Midazolam and BMS-986120 (NCT02208882) | Bristol-Myers Squibb | 2014-08-01 |
| Pharmacokinetic Profiles of Metformin With DW1029M (NCT02212756) | Dong Wha Pharmaceutical Co. Ltd. | 2014-08-01 |
| First Study of Oral Cysteamine in Cystic Fibrosis (NCT02212431) | University of Aberdeen | 2014-08-01 |
| Bioequivalence Study of Metformin Component of Fixed Dose Combination (FDC) Immediate Release (IR) Tablet of Canagliflozin and Metformin Compared to Metformin IR Tablet Co-administered With Canagliflozin in Healthy Fed and Fasted Participants (NCT02221180) | Janssen Research & Development, LLC | 2014-08-01 |
| The Application of Spasmolytic in PCLE Examination of Superior Gastrointestinal Endoscope (NCT02811341) | Shandong University | 2014-08-01 |
| Clinical Trial to Investigate the Pharmacokinetics Drug Interaction Between Metformin and Rosuvastatin (NCT02186483) | Jeil Pharmaceutical Co., Ltd. | 2014-08-01 |
| Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF (NCT02179255) | Center for Human Reproduction | 2014-08-01 |
| High Definition Cathodal Transcranial Direct Current Stimulation for Treatment of Refractory Partial Onset Epilepsy (NCT02264652) | NYU Langone Health | 2014-08-01 |
| A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy Participants (NCT02219256) | Takeda | 2014-08-01 |
| Pharmacokinetics and Tolerability of Minodronic Acid and Food and Age Effects on the Pharmacokinetics (NCT02295436) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2014-08-01 |
| Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1 (NCT02251457) | Ohio State University | 2014-08-01 |
| A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers (NCT02403713) | Mundipharma Research Limited | 2014-08-01 |
| A Study Of 4-1BB Agonist PF-05082566 Plus PD-1 Inhibitor MK-3475 In Patients With Solid Tumors (B1641003/KEYNOTE-0036) (NCT02179918) | Pfizer | 2014-08-01 |
| DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer (NCT02693236) | Affiliated Hospital to Academy of Military Medical Sciences | 2014-08-01 |
| A Study of LY3164530 in Participants With Cancer (NCT02221882) | Eli Lilly and Company | 2014-08-01 |
| Bioequivalence Study of Synflutide HFA Inhaler and Seretide Evohaler in Healthy Volunteers With Charcoal Block (NCT02466503) | Intech Biopharm Ltd. | 2014-08-01 |
| Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART (NCT02225665) | Sangamo Therapeutics | 2014-08-01 |
| Assessing Foot Injuries in Infantry Recruits Wearing Different Boots (NCT02810002) | Medical Corps, Israel Defense Force | 2014-08-01 |
| Chemotherapy Followed by Infusion of Partially HLA Matched Unrelated Donor Cells for Patients With AML Who Are Ineligible for Stem Cell Transplantation (NCT02189824) | University of Sydney | 2014-08-01 |
| Safety, Tolerability, and Pharmacokinetics of GS-5745 in Subjects With Rheumatoid Arthritis (NCT02176876) | Gilead Sciences | 2014-08-01 |
| Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD (NCT02221622) | University of Southern California | 2014-08-01 |
| Phase 1, TAK-648, Single-Rising Dose Study (NCT02684396) | Takeda | 2014-08-01 |
| Study of Sc-FOS for Pouchitis Prevention (NCT02203955) | Mayo Clinic | 2014-08-01 |
| Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis (NCT02135380) | Kasiak Research Pvt. Ltd. | 2014-08-01 |
| Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate Cancer (NCT02206334) | NRG Oncology | 2014-08-01 |
| A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer (NCT02231723) | Sumitomo Pharma America, Inc. | 2014-08-01 |
| Randomized, Crossover Safety and Pharmacokinetics Study of PT010 (NCT02197975) | Pearl Therapeutics, Inc. | 2014-08-01 |
| DC Vaccine Combined With CIK Cells in Patients With SCLC (NCT02688673) | Affiliated Hospital to Academy of Military Medical Sciences | 2014-08-01 |
| Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors (NCT02207348) | Novo Nordisk A/S | 2014-08-01 |
| Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects (NCT02334501) | Puma Biotechnology, Inc. | 2014-08-01 |
| A Pilot Trial Using BR55 Ultrasound Contrast Agent in the Assessment of Prostate Cancer (NCT02142608) | Bracco Diagnostics, Inc | 2014-08-01 |
| Follow-up Study to Assess One Boost Immunization With AFFITOPE® PD01A With Regard to Safety and Clinical Activity (NCT02216188) | Affiris AG | 2014-08-01 |
| Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy (NCT02256618) | Neonatal Encephalopathy Consortium, Japan | 2014-08-01 |
| Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia (NCT02108132) | Cairo University | 2014-08-01 |
| A Pilot, Exploratory, Non-Randomized Study of PET/CT With the Investigational Agent [18F] Fluciclatide to Correlate With Response to Anti-Cancer Therapy (NCT02193672) | M.D. Anderson Cancer Center | 2014-08-01 |
| Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast Cancer (NCT02361112) | Jiangsu HengRui Medicine Co., Ltd. | 2014-08-01 |
| Seattle-PAP Bubble Nasal CPAP and Work of Breathing (NCT02210026) | Seattle Children's Hospital | 2014-08-01 |
| Phase I Study of Kukoamine B Mesilate in Healthy Volunteers (NCT02219971) | Tianjin Chasesun Pharmaceutical Co., LTD | 2014-08-01 |
| A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin® Normal) and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes (NCT02213146) | Adocia | 2014-08-01 |
| A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers (NCT02073019) | BioLineRx, Ltd. | 2014-08-01 |
| Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris (NCT02218034) | Allergan | 2014-08-01 |
| Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer (NCT02116894) | Duke University | 2014-08-01 |
| Adapted Fluence Settings for Corneal Collagen Cross-linking in Mild to Moderate Progressive Keratoconus (NCT02507362) | Tehran University of Medical Sciences | 2014-08-01 |
| Study to Evaluate the Effect Of WCK 2349 on the QT/QTc Interval in Health Volunteers (NCT02217930) | Wockhardt | 2014-08-01 |
| Extended Infusion Carfilzomib on a Weekly Schedule in Patients With Advanced Solid Tumors (NCT02257476) | Emory University | 2014-08-01 |
| Safety Study of SGN-CD70A in Cancer Patients (NCT02216890) | Seagen Inc. | 2014-08-01 |
| This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas (NCT02171260) | Eisai Inc. | 2014-07-31 |
| A Study to Evaluate the Pharmacokinetics of a Single Dose of Tafenoquine Co-administered With Either Artemether + Lumefantrine or Dihydroartemisinin + Piperaquine Tetraphosphate (NCT02184637) | GlaxoSmithKline | 2014-07-31 |
| A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically (NCT02220348) | Forest Laboratories | 2014-07-31 |
| Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour) (NCT02203799) | Baylor College of Medicine | 2014-07-31 |
| A Study of Gemcitabine Plus Nab-paclitaxel With or Without FG-3019 in Participants With Locally Advanced, Unresectable Pancreatic Cancer (NCT02210559) | Kyntra Bio | 2014-07-31 |
| A Method Validation Study for Evaluation of Novel Treatments Limiting Pulmonary Oedema in Cardiac Failure (NCT02135861) | GlaxoSmithKline | 2014-07-30 |
| A First in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Intravenous (IV) Dose of GSK2831781 in Healthy Volunteers and Patients With Plaque Psoriasis (NCT02195349) | GlaxoSmithKline | 2014-07-30 |
| Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors (NCT01980667) | PharmaMar | 2014-07-30 |
| A Study of Oprozomib, Pomalidomide, and Dexamethasone in Adults With Primary Refractory or Relapsed and Refractory Multiple Myeloma (NCT01999335) | Amgen | 2014-07-30 |
| Botulinum Toxin for Pelvic Pain in Women With Endometriosis (NCT01553201) | National Institute of Neurological Disorders and Stroke (NINDS) | 2014-07-30 |
| First in Human Dose Escalation Study of Vactosertib (TEW-7197) in Subjects With Advanced Stage Solid Tumors (NCT02160106) | MedPacto, Inc. | 2014-07-29 |
| Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas (NCT02213913) | University of Chicago | 2014-07-29 |
| Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Clinical Activity of GSK2857916 (NCT02064387) | GlaxoSmithKline | 2014-07-29 |
| H7 Influenza Prime-Boost Regimens in Healthy Adults: Recombinant H7 DNA Plasmid Vaccine, VRC-FLUDNA071-00-VP, Administered Alone or With Monovalent Influenza Subunit Virion H7N9 Vaccine (MIV) as Prime With MIV Boost Compared to MIV Prime With MIV Boo... (NCT02206464) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-07-29 |
| Fetoscopic Meningomyelocele Repair Study (NCT02230072) | Baylor College of Medicine | 2014-07-29 |
| Study of Oral RXDX-101 in Adult Patients With Locally Advanced or Metastatic Cancer Targeting NTRK1, NTRK2, NTRK3, ROS1, or ALK Molecular Alterations. (NCT02097810) | Hoffmann-La Roche | 2014-07-28 |
| Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (NCT02118285) | Masonic Cancer Center, University of Minnesota | 2014-07-28 |
| Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy (NCT02205398) | Novartis Pharmaceuticals | 2014-07-28 |
| Treatment of Advanced Melanoma With MK-3475 and Peginterferon (NCT02112032) | Hassane M. Zarour, MD | 2014-07-24 |
| The ONE Study M Reg Trial (NCT02085629) | University of Regensburg | 2014-07-24 |
| Alternating Systemic Chemotherapy and Intra-Arterial Melphalan (IAM) Chemotherapy in Children With Intra-Ocular Retinoblastoma (NCT02116959) | University of California, San Francisco | 2014-07-23 |
| Study of the Safety and Effectiveness of LGH447 and BYL719 in Patients With Relapsed and Refractory Multiple Myeloma (NCT02144038) | Novartis Pharmaceuticals | 2014-07-23 |
| A Study of ALS-008176 in Infants Hospitalized With RSV (NCT02202356) | Alios Biopharma Inc. | 2014-07-23 |
| Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study (NCT02255617) | University of Alberta | 2014-07-23 |
| A Phase Ⅰb Study of Remimazolam Tosylate in Healthy Volunteers (NCT03444480) | Jiangsu HengRui Medicine Co., Ltd. | 2014-07-23 |
| Evaluation of SAR408701 in Patients With Advanced Solid Tumors (NCT02187848) | Sanofi | 2014-07-23 |
| Mobile Health App to Reduce Diabetes in Latina Women (NCT04149054) | Environment and Health Group, Inc. | 2014-07-22 |
| Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies (NCT02048917) | University of Kentucky | 2014-07-22 |
| A Study of TAS-120 in Patients With Advanced Solid Tumors (NCT02052778) | Taiho Oncology, Inc. | 2014-07-21 |
| Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma (NCT02049541) | Kami Maddocks, MD | 2014-07-21 |
| A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer (NCT02138734) | ImmunityBio, Inc. | 2014-07-21 |
| Targeted Busulfan, Fludarabine Conditioning Regimen for Hematopoietic Stem Cell Transplantation in GRD (NCT02034630) | Seoul National University Hospital | 2014-07-21 |
| Trabectedin Plus Olaparib in Metastatic or Advanced Sarcomas (TOMAS) (NCT02398058) | Italian Sarcoma Group | 2014-07-20 |
| A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME (NCT02193113) | KalVista Pharmaceuticals, Ltd. | 2014-07-18 |
| Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies (NCT02070406) | Jonsson Comprehensive Cancer Center | 2014-07-17 |
| Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers (NCT02178722) | Incyte Corporation | 2014-07-17 |
| China HVT Safety, PK, PD (NCT02135640) | GlaxoSmithKline | 2014-07-17 |